Episode 2 - The future is now-combination therapies in DLBCL
Update: 2025-11-24
Description
Interested in novel combination therapies for patients with diffuse large B-cell lymphoma (DLBCL)? Dr. Marie Hu joins the podcast to share her perspectives on emerging treatments and the impact of stronger academic-community collaborations on patient care for relapsed and refractory patients with DLBCL.
Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & Blood
Guest: Dr. Marie Hu, Assistant Professor of Medicine, University of Minnesota
Comments
In Channel




